Apolipoprotein A-II, HDL metabolism and atherosclerosis

Atherosclerosis

Volumn 164, Issue 1, 2002, Pages 1-13

  Tailleux, Anne ^a   Duriez, Patrick ^a   Fruchart, Jean Charles ^a   Clavey, Véronique ^a  

^a INSERM   (France)

Author keywords

Apolipoprotein A II; Atherosclerosis; Lipoprotein metabolism; Reverse cholesterol transport; Transgenic mice

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; CARRIER PROTEIN; CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN; LIVER TRIACYLGLYCEROL LIPASE; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE;

ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD LEVEL; CARDIOVASCULAR RISK; CELL CULTURE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; DISEASE ASSOCIATION; DISEASE MARKER; GLUCOSE METABOLISM; HEART INFARCTION; HUMAN; IN VITRO STUDY; ISCHEMIC HEART DISEASE; LIPID METABOLISM; LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVIEW; TRANSGENIC ANIMAL; TRANSGENICS; ANIMAL; ARTERIOSCLEROSIS; CORONARY ARTERY DISEASE; GENETICS; METABOLISM; MOUSE; TRANSGENIC MOUSE;

ANIMAL; APOLIPOPROTEIN A-I; APOLIPOPROTEIN A-II; ARTERIOSCLEROSIS; CORONARY DISEASE; GLUCOSE; HUMAN; LIPOPROTEIN LIPASE; LIPOPROTEINS, HDL CHOLESTEROL; MICE; MICE, TRANSGENIC; ANIMALS; CHOLESTEROL, HDL; HUMANS;

EID: 0035996574     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00751-1     Document Type: Review

References (91)

1. Differential tissue-specific expression of human apoA-I and apoA-II
2. Isolation and characterization of apolipoproteins A-I, A-II, and A-IV
3. Amino acid sequence of human apoLp-Gln-II (apoA-II), an apolipoprotein isolated from the high-density lipoprotein complex
4. Genetic control of lipid transport in mice. II. Genes controlling structure of high density lipoproteins
5. The human apolipoprotein A-II gene is located on chromosome 1
6. Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor
7. Molecular mechanism of action of the fibrates
8. Retinoids increase human apolipoprotein A-II expression through activation of the retinoid X receptor but not the retinoic acid receptor
9. Regulation of human apo A-II promoter by the orphan receptor ROR-a is mediated through PPAR-a acting as a docking factor
10. DNA binding specificity and transactivation properties of SREBP-2 bound to multiple sites on the human apoA-II promoter
11. Apolipoprotein A-II: A protein in search of a function
12. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease
13. Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis
14. Plasma high density lipoproteins. Metabolism and relationship to atherogenesis
15. Epidemiologic aspects of lipid abnormalities
16. A splice-junction mutation responsible for familial apolipoprotein A-II deficiency
17. The apolipoprotein AII gene is not a risk factor for development ischemic heart disease in the Moscow population
18. Multivariate analyses of serum apolipoproteins and risk factors in relation to acute myocardial infarction
19. Quantitative determination of human plasma apo-AII by a noncompetitive enzyme-linked immunosorbent assay
20. Decreased postprandial high density lipoprotein cholesterol and apolipoproteins A-I and E in normolipidemic smoking men: Relations with lipid transfer proteins and LCAT activities
21. Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but no A-II
22. High-density lipoprotein subclasses and apolipoprotein A-I
23. Characterization of two HDL subfractions and LpA-I, LpA-I:A-II distribution profiles and clinical characteristics of hyperalphalipoproteinemic subjects without cholesterol ester transfer protein deficiency
24. Familial deficiency of apolipoproteins A-I and C-III and precocious coronary-artery disease
25. Apolipoprotein A-I Q[-2]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia
26. Human apolipoprotein A-I and A-II metabolism
27. Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women
28. Physiologic mechanisms for reduced apolipoprotein A-I concentrations associated with low levels of high density lipoprotein cholesterol in patients with normal plasma lipids
29. Stable isotope turnover of apolipoproteins of high-density lipoproteins in humans
30. Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution
31. In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I,A-II
32. Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: Cholesterol acyltransferase deficiency and fish-eye disease
33. Postprandial lipemia differentially influences high density lipoprotein subpopulations LpAI and LpAI,AII
34. Apolipoprotein A-II production rate is a major factor regulating the distribution of apolipoprotein A-I among HDL subclasses LpA-I and LpA-I:A-II in normolipidemic humans
35. ApoA-II kinetics in humans using endogenous labeling with stable isotopes: Slower turnover of apoA-II compared with the exogenous radiotracer method
36. In vivo metabolism of apo A-I and apo A-II in subjects with apo A- I(Lys107(0) associated with reduced HDL cholesterol and Lp(AI w AII) deficiency
37. High density lipoprotein and coronary heart disease: Insights from mutations leading to low high density lipoprotein
38. High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport
39. Remodelling of high density lipoproteins by plasma factors
40. Human apolipoprotein A-IV binds to apolipoprotein A-I/A-II receptor sites and promotes cholesterol efflux from adipose cells
41. Purification of an apolipoprotein A binding protein from mouse adipose cells
42. Modulation of cholesterol efflux from Fu5AH hepatoma cells by the apolipoprotein content of high density lipoprotein particles. Particles containing various proportions of apolipoproteins A-I and A-II
43. Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles
44. Cholesterol efflux from cells to immunopurified subfractions of human high density lipoprotein: LP-AI and LP-AI/AII
45. Cholesterol efflux from macrophages mediated by high-density lipoprotein subfractions, which differ principally in apolipoprotein A- I and apolipoprotein A-II ratios
46. Cellular cholesterol efflux. Role of cell membrane kinetic pools and interaction with apolipoproteins AI, AII, and Cs
47. Effects of interactions of apolipoprotein A-II with apolipoproteins A-I or A-IV on [3H]cholesterol efflux and uptake in cell culture
48. Cholesterol efflux from adipose cells is coupled to diacylglycerol production and protein kinase C activation
49. Differential role of apolipoprotein AI-containing particles in cholesterol efflux from adipose cells
50. The molecular structure of apolipoprotein A-II modulates the capacity of HDL to promote cell cholesterol efflux
51. Comparison of the structural and functional effects of monomeric and dimeric human apolipoprotein A-II in high density lipoprotein particles
52. Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin: Cholesterol acyltransferase
53. Activation of the enzymic activity of hepatic lipase by apolipoprotein A-II. Characterization of a major component of high density lipoprotein as the activating plasma component in vitro
54. Effect of apolipoproteins on the hepatic lipase-catalyzed hydrolysis of human plasma high density lipoprotein2-triacylglycerols
55. Apolipoprotein A-II influences the substrate properties of human HDL2 and HDL3 for hepatic lipase
56. Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice
57. Recruitment of cell phospholipids and cholesterol by apolipoproteins A- II and A-I: Formation of nascent apolipoprotein-specific HDL that differ in size, phospholipid composition, and reactivity with LCAT
58. Discoidal complexes of A and C apolipoproteins with lipids and their reactions with lecithin: Cholesterol acyltransferase
59. The effect of apolipoprotein A-II on the structure and function of apolipoprotein A-I in a homogeneous reconstituted high density lipoprotein particle
60. Lipid-free apolipoproteins A-I and A-II promote remodeling of reconstituted high density lipoproteins and alter their reactivity with lecithin:cholesterol acyltransferase
61. Displacement of apo A-I from HDL by apo A-II or its C-terminal helix promotes the formation of pre-beta1 migrating particles and decreases LCAT activation
62. Different reactivities of high density lipoprotein2 subfractions with hepatic lipase
63. The influence of apolipoproteins on the hepatic lipase-mediated hydrolysis of high density lipoprotein phospholipid and triacylglycerol
64. Dissociation of lipid-free apolipoprotein A-I from high density lipoproteins
65. Influence of apolipoprotein composition of high density lipoprotein particles on cholesteryl ester transfer protein activity. Particles containing various proportions of apolipoproteins AI and AII
66. Selective uptake of cholesteryl esters from high-density lipoprotein-derived LpA-I and LpA-I:A-II particles by hepatic cells in culture
67. Cholesterol efflux, cholesterol esterification, and cholesteryl ester transfer by LpA-I and LpA-I/A-II in native plasma
68. Apolipoproteins of HDL can directly mediate binding to the scavenger receptor SR-BI, an HDL receptor that mediates selective lipid uptake
69. Apolipoprotein AII enrichment of HDL enhances their affinity for class B type I scavenger receptor but inhibits specific cholesteryl ester uptake
70. Apolipoprotein A-I conformation markedly influences HDL interaction with scavenger receptor BI
71. Apolipoprotein A-II modulates the binding and selective lipid uptake of reconstituted high density lipoprotein by scavenger receptor BI
72. Displacement of the human apoprotein A-I by the human apoprotein A-II from complexes of (apoprotein A-I)-phosphatidylcholine-cholesterol
73. On the mechanism of the displacement of apolipoprotein A-I by apolipoprotein A-II from the high density lipoprotein surface. Effect of concentration and molecular forms of apolipoprotein A-II
74. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II [published erratum appears in Science 1993;262(5131):164]
75. Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles
76. Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility
77. Protein composition determines the anti-atherogenic properties of HDL in transgenic mice
78. Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II
79. Overexpression of human apolipoprotein A-II in mice induces hypertriglyceridemia due to defective very low density lipoprotein hydrolysis
80. Decreased susceptibility to diet-induced atherosclerosis in human apolipoprotein A-II transgenic mice [in Process Citation]
81. A 700-bp fragment of the human antithrombin III promoter is sufficient to confer high, tissue-specific expression on human apolipoprotein A-II in transgenic mice
82. Expression of human apolipoprotein A-II and its effect on high density lipoproteins in transgenic mice
83. Human apolipoprotein A-II is a pro-atherogenic molecule when it is expressed in transgenic mice at a level similar to that in humans: Evidence of a potentially relevant species-specific interaction with diet
84. Free cholesterol deposition in the cornea of human apolipoprotein A-II transgenic mice with functional lecithin: Cholesterol acyltransferase deficiency
85. Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses
86. Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism
87. Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-beta particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transport
88. Increased production of very-low-density lipoproteins in transgenic mice overexpressing human apolipoprotein A-II and fed with a high-fat diet [In Process Citation]
89. The properties of HDL in genetically engineered mice
90. Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia